$MSSA
Metal Sky Star Acquisition Corp Stock $mssa

$mssa Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000182912623007427 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$200.5K	$110.6K	$110.1K
YoY Change	72.03%	0.49%	603.54%
Operating Profit		-$110.6K	-$110.1K
YoY Change		0.48%	2723.18%
Interest Expense	$628.3K	$773.0K	$519.9K
YoY Change	-36.7%	48.68%
% of Operating Profit
Other Income/Expense, Net		$773.0K	$519.9K
YoY Change		48.68%
Pretax Income	$427.9K	$662.4K	$409.8K
YoY Change	-51.16%	61.63%	-2718.61%
Income Tax
% Of Pretax Income
Net Earnings	-$4.691M	$662.4K	$409.8K
YoY Change	-635.38%	61.63%	-2718.61%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.64	$0.08	$27.87K
COMMON SHARES
Basic Shares Outstanding	6.407M shares	8.820M shares	14.71M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$60.79M	$115.9M
YoY Change		-47.54%
Cash & Equivalents		$0.00	$188.4K
Short-Term Investments		$60.79M	$115.7M
Other Short-Term Assets	$1.880K	$22.41K	$267.8K
YoY Change	-99.14%	-91.63%	-20.26%
Inventory
Prepaid Expenses	$1.875K	$21.25K
Receivables
Other Receivables
Total Short-Term Assets	$1.875K	$60.81M	$115.9M
YoY Change	-100.0%	-47.55%	34429.06%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$35.36M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$35.36M	$1.00	-$5.00
YoY Change		-120.0%
TOTAL ASSETS
Total Short-Term Assets	$1.875K	$60.81M	$115.9M
Total Long-Term Assets	$35.36M	$1.00	-$5.00
Total Assets	$35.36M	$60.81M	$115.9M
YoY Change	-69.75%	-47.55%	34429.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$298.3K	$303.5K	$79.63K
YoY Change	103.27%	281.14%	201.05%
Deferred Revenue
YoY Change
Short-Term Debt	$2.172M	$1.935M	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.847M	$5.304M	$2.955M
YoY Change	-5.8%	79.53%	805.08%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.875M
YoY Change
Total Long-Term Liabilities	$2.875M	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.847M	$5.304M	$2.955M
Total Long-Term Liabilities	$2.875M	$0.00	$0.00
Total Liabilities	$5.722M	$5.304M	$2.955M
YoY Change	89.35%	79.53%	805.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.773M	-$5.285M	-$2.690M
YoY Change	105.69%	96.47%
Common Stock	$3.205K	$3.205K	$3.205K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.770M	-$5.282M	-$2.687M
YoY Change
Total Liabilities & Shareholders Equity	$35.36M	$60.81M	$115.9M
YoY Change	-69.75%	-47.55%	34429.06%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$4.691M	$662.4K	$409.8K
YoY Change	-635.38%	61.63%	-2718.61%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$189.5K	-$78.50K	-$56.24K
YoY Change	-2043.79%	39.58%	-45.9%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$26.06M	-$561.4K	$0.00
YoY Change
Cash From Investing Activities	$26.06M	-$561.4K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-26.25M	639.9K	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	189.5K	-78.50K	-56.24K
Cash From Investing Activities	26.06M	-561.4K	0.000
Cash From Financing Activities	-26.25M	639.9K	0.000
Net Change In Cash	-1.160K	-10.00	-56.24K
YoY Change	-88.1%	-99.98%	-125.44%
FREE CASH FLOW
Cash From Operating Activities	$189.5K	-$78.50K	-$56.24K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001882464
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q4	MSSAU	Promissory Note Related Party PromissoryNoteRelatedParty	-0	usd
CY2023Q3	MSSAU	Deferred Underwriting Commission DeferredUnderwritingCommission	2875000	usd
CY2022Q4	MSSAU	Due To Related Party DueToRelatedParty		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	MSSAU	Increase Decrease In Deferred Offering Costs IncreaseDecreaseInDeferredOfferingCosts		usd
	MSSAU	Increase Decrease In Accrued Offering Costs IncreaseDecreaseInAccruedOfferingCosts		usd
	MSSAU	Cash Withdrawn From Trust Account To Redeem Public Shares CashWithdrawnFromTrustAccountToRedeemPublicShares		usd
	MSSAU	Borrowings From Related Party BorrowingsFromRelatedParty		usd
	MSSAU	Proceeds From Proceeds From Sale Of Private Placement Units ProceedsFromProceedsFromSaleOfPrivatePlacementUnits		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	MSSAU	Payment Of Offering Costs PaymentOfOfferingCosts		usd
	MSSAU	Redemption Of Public Shares RedemptionOfPublicShares		usd
	MSSAU	Deferred Underwriting Compensation DeferredUnderwritingCompensation		usd
	MSSAU	Initial Ordinary Shares Subject To Possible Redemption InitialOrdinarySharesSubjectToPossibleRedemption		usd
	MSSAU	Reclassification Of Offering Costs Related To Public Shares ReclassificationOfOfferingCostsRelatedToPublicShares		usd
	MSSAU	Change In Value Of Ordinary Shares Subject To Redemption ChangeInValueOfOrdinarySharesSubjectToRedemption		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41344
	dei	Entity Registrant Name EntityRegistrantName	METAL SKY STAR ACQUISITION CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
	dei	Entity Address Address Line1 EntityAddressAddressLine1	132 West 31st Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	First Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
	dei	City Area Code CityAreaCode	(332)
	dei	Local Phone Number LocalPhoneNumber	237-6141
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6407416	shares
CY2023Q3	MSSAU	Cash Held In Escrow CashHeldInEscrow	1164	usd
CY2022Q4	MSSAU	Cash Held In Escrow CashHeldInEscrow	178652	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	21250	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	39683	usd
CY2023Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	60787237	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	116673481	usd
CY2023Q3	us-gaap	Assets Assets	60809651	usd
CY2022Q4	us-gaap	Assets Assets	116891816	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	303492	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	146738	usd
CY2023Q3	MSSAU	Due To Related Party DueToRelatedParty	190683	usd
CY2023Q3	MSSAU	Promissory Note Related Party PromissoryNoteRelatedParty	1935248	usd
CY2022Q4	MSSAU	Deferred Underwriting Commission DeferredUnderwritingCommission	2875000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5304423	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3021738	usd
CY2023Q3	us-gaap	Liabilities Liabilities	5304423	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3021738	usd
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5614676	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11500000	shares
CY2023Q3	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	60787237	usd
CY2022Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	116673481	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3205000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3205000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3205000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3205000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	3205	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3205	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5285214	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2806608	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5282009	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2803403	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60809651	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116891816	usd
CY2023Q3	MSSAU	Formation And Operational Costs FormationAndOperationalCosts	110635	usd
CY2022Q3	MSSAU	Formation And Operational Costs FormationAndOperationalCosts	110104	usd
	MSSAU	Formation And Operational Costs FormationAndOperationalCosts	598030	usd
	MSSAU	Formation And Operational Costs FormationAndOperationalCosts	282269	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-110635	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-110104	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-598030	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-282269	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-110635	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-110104	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-598030	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-282269	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	516036	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	298932	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2065362	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	459842	usd
CY2023Q3	MSSAU	Unrealized Gained On Marketable Securities Held In Trust Account UnrealizedGainedOnMarketableSecuritiesHeldInTrustAccount	256975	usd
CY2022Q3	MSSAU	Unrealized Gained On Marketable Securities Held In Trust Account UnrealizedGainedOnMarketableSecuritiesHeldInTrustAccount	220985	usd
	MSSAU	Unrealized Gained On Marketable Securities Held In Trust Account UnrealizedGainedOnMarketableSecuritiesHeldInTrustAccount	256975	usd
	MSSAU	Unrealized Gained On Marketable Securities Held In Trust Account UnrealizedGainedOnMarketableSecuritiesHeldInTrustAccount	220985	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	773011	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	519917	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2322337	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	680827	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	662376	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	409813	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1724307	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	398558	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	662376	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	409813	usd
	us-gaap	Net Income Loss NetIncomeLoss	1724307	usd
	us-gaap	Net Income Loss NetIncomeLoss	398558	usd
CY2023Q3	MSSAU	Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption	5614676	shares
CY2022Q3	MSSAU	Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption	11500000	shares
	MSSAU	Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption	6110197	shares
	MSSAU	Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption	7540293	shares
CY2023Q3	MSSAU	Basic And Diluted Net Income Loss Per Share Ordinary Shares Subject To Redemption BasicAndDilutedNetIncomeLossPerShareOrdinarySharesSubjectToRedemption	0.16
CY2022Q3	MSSAU	Basic And Diluted Net Income Loss Per Share Ordinary Shares Subject To Redemption BasicAndDilutedNetIncomeLossPerShareOrdinarySharesSubjectToRedemption	0.04
	MSSAU	Basic And Diluted Net Income Loss Per Share Ordinary Shares Subject To Redemption BasicAndDilutedNetIncomeLossPerShareOrdinarySharesSubjectToRedemption	0.42
	MSSAU	Basic And Diluted Net Income Loss Per Share Ordinary Shares Subject To Redemption BasicAndDilutedNetIncomeLossPerShareOrdinarySharesSubjectToRedemption	0.79
CY2023Q3	MSSAU	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Ordinary Shares BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableOrdinaryShares	3205000	shares
CY2022Q3	MSSAU	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Ordinary Shares BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableOrdinaryShares	3205000	shares
	MSSAU	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Ordinary Shares BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableOrdinaryShares	3205000	shares
	MSSAU	Basic And Diluted Weighted Average Shares Outstanding Nonredeemable Ordinary Shares BasicAndDilutedWeightedAverageSharesOutstandingNonredeemableOrdinaryShares	3091374	shares
CY2023Q3	MSSAU	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.08
CY2022Q3	MSSAU	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.01
	MSSAU	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-0.27
	MSSAU	Basic And Diluted Net Loss Per Share BasicAndDilutedNetLossPerShare	-1.80
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2803403	usd
CY2023Q1	MSSAU	Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Additional Funding For Business Combination Extension SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionAdditionalFundingForBusinessCombinationExtension	-757676	usd
CY2023Q1	MSSAU	Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount	-858920	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	595502	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-3824497	usd
CY2023Q2	MSSAU	Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Additional Funding For Business Combination Extension SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionAdditionalFundingForBusinessCombinationExtension	-561466	usd
CY2023Q2	MSSAU	Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount	-690406	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	466429	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-4609940	usd
CY2023Q3	MSSAU	Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount	-773011	usd
CY2023Q3	MSSAU	Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Additional Funding For Business Combination Extension SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionAdditionalFundingForBusinessCombinationExtension	-561434	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	662376	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5282009	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	150	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-3550	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3400	usd
CY2022Q2	MSSAU	Issuance Of Public Shares At Initial Public Offering IssuanceOfPublicSharesAtInitialPublicOffering	115000000	usd
CY2022Q2	MSSAU	Underwriters Discount UnderwritersDiscount	-5175000	usd
CY2022Q2	MSSAU	Offering Costs OfferingCosts	-529741	usd
CY2022Q2	MSSAU	Sale Of Shares To Sponsor In Private Placement SaleOfSharesToSponsorInPrivatePlacement	3300000	usd
CY2022Q2	MSSAU	Initial Value Of Ordinary Stock Subject To Possible Redemption InitialValueOfOrdinaryStockSubjectToPossibleRedemption	101200000	usd
CY2022Q2	MSSAU	Allocation Of Offering Costs Related To Redeemable Shares AllocationOfOfferingCostsRelatedToRedeemableShares	5020172	usd
CY2022Q2	MSSAU	Accretion Of Carrying Value Of Redeemable Shares To Redemption Value AccretionOfCarryingValueOfRedeemableSharesToRedemptionValue	-18820172	usd
CY2022Q2	MSSAU	Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount	-160910	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-7705	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2576756	usd
CY2022Q3	MSSAU	Subsequent Measurement Of Ordinary Shares Subject To Redemption Interest Earned And Unrealized Gain On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount	-519917	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	409813	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2686860	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1724307	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	398558	usd
	MSSAU	Interest Earned In Trust Account InterestEarnedInTrustAccount	2065362	usd
	MSSAU	Interest Earned In Trust Account InterestEarnedInTrustAccount	459842	usd
	MSSAU	Unrealized Gain On Marketable Securities Held In Trust Account UnrealizedGainOnMarketableSecuritiesHeldInTrustAccount	256975	usd
	MSSAU	Unrealized Gain On Marketable Securities Held In Trust Account UnrealizedGainOnMarketableSecuritiesHeldInTrustAccount	220985	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	76558	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	78134	usd
	MSSAU	Increase Decrease In Deferred Offering Costs IncreaseDecreaseInDeferredOfferingCosts	-236522	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	58125	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	157500	usd
	MSSAU	Increase Decrease In Accrued Offering Costs IncreaseDecreaseInAccruedOfferingCosts	-31550	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	156754	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	78828	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-422843	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77835	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1880576	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	115000000	usd
	MSSAU	Cash Withdrawn From Trust Account To Redeem Public Shares CashWithdrawnFromTrustAccountToRedeemPublicShares	60089158	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	58208582	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-115000000	usd
	MSSAU	Borrowings From Related Party BorrowingsFromRelatedParty	2125931	usd
	MSSAU	Proceeds From Proceeds From Sale Of Private Placement Units ProceedsFromProceedsFromSaleOfPrivatePlacementUnits	3300000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	114700000	usd
	MSSAU	Payment Of Offering Costs PaymentOfOfferingCosts	2829741	usd
	MSSAU	Redemption Of Public Shares RedemptionOfPublicShares	60089158	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-57963227	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	115170259	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-177488	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	92424	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	178652	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95978	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1164	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188402	usd
	MSSAU	Deferred Underwriting Compensation DeferredUnderwritingCompensation	2875000	usd
	MSSAU	Initial Ordinary Shares Subject To Possible Redemption InitialOrdinarySharesSubjectToPossibleRedemption	101200000	usd
	MSSAU	Reclassification Of Offering Costs Related To Public Shares ReclassificationOfOfferingCostsRelatedToPublicShares	-5020172	usd
	MSSAU	Change In Value Of Ordinary Shares Subject To Redemption ChangeInValueOfOrdinarySharesSubjectToRedemption	18820172	usd
	MSSAU	Subsequent Measurement Of Ordinary Share Subject To Redemption Interest Earned And Unrealized Gain On Trust Account SubsequentMeasurementOfOrdinaryShareSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount	4202913	usd
	MSSAU	Subsequent Measurement Of Ordinary Share Subject To Redemption Interest Earned And Unrealized Gain On Trust Account SubsequentMeasurementOfOrdinaryShareSubjectToRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount	680827	usd
	MSSAU	Redemptions Shares RedemptionsShares	5885324	shares
CY2023Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	60787237	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	116673481	usd
	MSSAU	Trust Account Amount TrustAccountAmount	50000	usd
	MSSAU	Ordinary Shares OrdinaryShares	2412260	shares
CY2023Q2	MSSAU	Merger Agreement Value MergerAgreementValue	350000000	usd
CY2022Q2	MSSAU	Subscription Of Ordinary Shares SubscriptionOfOrdinaryShares	25000	usd
CY2022Q2	MSSAU	Proceeds From Ipo And Private Placement ProceedsFromIpoAndPrivatePlacement	115682250	usd
CY2023Q3	us-gaap	Cash Cash	1164	usd
CY2023Q3	MSSAU	Working Capital WorkingCapital	2407009	usd
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	60787237	usd
CY2023Q3	MSSAU	Deferred Underwriting Commissions DeferredUnderwritingCommissions	2875000	usd
CY2022Q4	us-gaap	Cash Cash	178652	usd
CY2022Q4	MSSAU	Working Capital WorkingCapital	71597	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	116673481	usd
CY2022Q4	MSSAU	Deferred Underwriting Commissions DeferredUnderwritingCommissions	2875000	usd
CY2023Q3	us-gaap	Cash Cash	1164	usd
CY2023Q3	MSSAU	Working Capital WorkingCapital	2407009	usd
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	60787237	usd
CY2023Q3	MSSAU	Deferred Underwriting Commissions DeferredUnderwritingCommissions	2875000	usd
CY2022Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	90000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	58333	usd
CY2023Q1	MSSAU	Extension Fee ExtensionFee	187155	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zuEq1ceLQ5Gg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zHHdLdKpXleg">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	MSSAU	Cash Held In Escrow CashHeldInEscrow	1164	usd
CY2022Q4	MSSAU	Cash Held In Escrow CashHeldInEscrow	178652	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	773011	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	516036	usd
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	256975	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2322337	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2065362	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	256975	usd
	MSSAU	Withdrawn From Trust Account WithdrawnFromTrustAccount	60089158	usd
	MSSAU	Trust Account For Redemption Of Public Shares TrustAccountForRedemptionOfPublicShares	5885324	shares
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	519917	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	298932	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	220985	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	680827	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	459842	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	220985	usd
CY2023Q1	MSSAU	Number Of Public Shares Redeemed NumberOfPublicSharesRedeemed	5885324	shares
CY2023Q3	MSSAU	Promissory Note Related Party PromissoryNoteRelatedParty	1935248	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
	MSSAU	Warrants Exercisable WarrantsExercisable	5915000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zLtlJ1Ig3Ael" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zgLWQc1cM7Ne">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	MSSAU	Due To Related Party DueToRelatedParty	190683	usd
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	115000000	usd
	MSSAU	Proceeds Allocated To Public Rights ProceedsAllocatedToPublicRights	-8510000	usd
	MSSAU	Proceeds Allocated To Public Warrants ProceedsAllocatedToPublicWarrants	-5290000	usd
	MSSAU	Allocation Of Offering Costs Related To Ordinary Shares AllocationOfOfferingCostsRelatedToOrdinaryShares	-5020172	usd
	MSSAU	Redemption Of Public Shares RedemptionOfPublicShares	60089158	usd
	us-gaap	Accretion Expense AccretionExpense	20700749	usd
	MSSAU	Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption Interest Earned And Unrealized Gain On Trust Account SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemptionInterestEarnedAndUnrealizedGainOnTrustAccount	3995818	usd
	MSSAU	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	60787237	usd
CY2022Q2	MSSAU	Related Party Service Fee RelatedPartyServiceFee	10000	usd
CY2023Q3	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
CY2023Q3	MSSAU	Deferred Underwriting Commissions DeferredUnderwritingCommissions	2875000	usd
CY2022Q4	MSSAU	Deferred Underwriting Commissions DeferredUnderwritingCommissions	2875000	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	25000	usd
	MSSAU	Monthly Payment Description MonthlyPaymentDescription	The Company entered into the agreement with a retainer of $5,000 per month starting from April 1, 2022.
CY2023Q3	us-gaap	Payments For Fees PaymentsForFees	15000	usd
CY2022Q3	us-gaap	Payments For Fees PaymentsForFees	15000	usd
	us-gaap	Payments For Fees PaymentsForFees	45000	usd
	us-gaap	Payments For Fees PaymentsForFees	30000	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	3500	usd
	us-gaap	Professional Fees ProfessionalFees	163000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of the ordinary shares are entitled to one vote for each ordinary share.
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3205000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3205000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	11500000	shares

Files In Submission

Name	View Source	Status
mssau-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001829126-23-007427-index-headers.html	Edgar Link	pending
0001829126-23-007427-index.html	Edgar Link	pending
0001829126-23-007427.txt	Edgar Link	pending
0001829126-23-007427-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
metalsky_10q.htm	Edgar Link	pending
metalsky_ex31-1.htm	Edgar Link	pending
metalsky_ex31-2.htm	Edgar Link	pending
metalsky_ex32-1.htm	Edgar Link	pending
metalsky_ex32-2.htm	Edgar Link	pending
mssau-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
mssau-20230930_def.xml	Edgar Link	unprocessable
mssau-20230930_lab.xml	Edgar Link	unprocessable
mssau-20230930_pre.xml	Edgar Link	unprocessable
metalsky_10q_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MSSA
Metal Sky Star Acquisition Corp Stock $mssa

2023 Q4 Form 10-Q Financial Statement

#000182912623007427 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MSSA Metal Sky Star Acquisition Corp Stock $mssa

2023 Q4 Form 10-Q Financial Statement

#000182912623007427 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MSSA
Metal Sky Star Acquisition Corp Stock $mssa